EUVIMEDEUVIMED entdecken
Crossref

Pharmacogenomics has two evidence bases, not one: Specific gene-drug pairs against panel-based pre-emptive testing for preventing adverse drug reactions

James Bennett, Andrew Mitchell

Biomed Pharma Reviews · 25.01.2026 · 2 (1) · 1-9

DOI: 10.62587/bmpr.2.1.2026.1-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomed Pharma Reviews, online erschienen am 25.01.2026. Verfasst von James Bennett und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Bennett, J., & Mitchell, A. (2026). Pharmacogenomics has two evidence bases, not one: Specific gene-drug pairs against panel-based pre-emptive testing for preventing adverse drug reactions. Biomed Pharma Reviews, 2(1), 1-9. https://doi.org/10.62587/bmpr.2.1.2026.1-9

Vancouver

Bennett J, Mitchell A. Pharmacogenomics has two evidence bases, not one: Specific gene-drug pairs against panel-based pre-emptive testing for preventing adverse drug reactions. Biomed Pharma Reviews. 2026;2(1):1-9. doi:10.62587/bmpr.2.1.2026.1-9

BibTeX
@article{Bennett2026,
  author = {Bennett, James and Mitchell, Andrew},
  title = {Pharmacogenomics has two evidence bases, not one: Specific gene-drug pairs against panel-based pre-emptive testing for preventing adverse drug reactions},
  journal = {Biomed Pharma Reviews},
  year = {2026},
  volume = {2},
  number = {1},
  pages = {1--9},
  doi = {10.62587/bmpr.2.1.2026.1-9}
}
Kostenlos starten →